Search

Brandon Brauer's practice focuses primarily on commercial real estate transactions, including leases, purchases and sales, financings, construction contracts and condominium regime work. Brandon's experience includes single-asset and portfolio transactions with respect to multifamily properties...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

Chihao Wang is a registered patent agent who draws on his scientific background in biochemistry to assist clients in protecting their innovations. Chihao has intellectual property experience in a broad spectrum of technology areas, including biotechnology, biochemistry, molecular biology...

George Naya is a seasoned corporate lawyer with a broad practice centered on U.S. securities laws and corporate governance. He advises companies in a diverse array of industries and has extensive experience in both domestic and international capital markets transactions. In addition to his time in...

Geoffrey Langan advises clients on complex commercial real estate leasing and transactions and related litigation. His deep knowledge of the commercial real estate market is informed by his past work for more than a decade as in-house real estate counsel for the largest privately owned shopping...

Monaf Awwa, Ph.D., is a patent agent who helps clients in the biopharmaceutical, medical device and chemical industries protect their intellectual property by drafting their patent applications, preparing USPTO office action responses, and handling patent prosecutions. He also provides clients with...

Kevin M. Levy focuses primarily on real estate matters, including property sales and acquisitions, leases, commercial real estate lending and borrowing, development projects and real estate tax appeals. Kevin also advised clients on COVID-19 regulatory compliance and has commented extensively on...